Oral transmucosal fentanyl citrate as breakthrough pain relieving medication: A pilot study
Background: Breakthrough pain in cancer patients is a common and distressing symptom that significantly impacts their quality of life. Traditional pain management strategies often fail to provide adequate relief. Oral transmucosal fentanyl citrate (OTFC) has emerged as a rapid-onset opioid analgesic...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-08-01
|
| Series: | Current Medicine Research and Practice |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/cmrp.cmrp_72_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|